Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00471445

Organisation Name: University of Rochester

Overal Status: Completed

Start Date: October 2007

Last Update: November 9, 2015

Lead Sponsor: Gary Morrow

Brief Summary: RATIONALE: Topical cream containing amitriptyline and ketamine may help relieve pain, numbness, tingling, and other symptoms of peripheral neuropathy. It is not yet known whether topical amitriptyline and ketamine cream is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy.

PURPOSE: This randomized phase III trial is studying the side effects and how well topical amitriptyline and ketamine cream work compared with a placebo in treating peripheral neuropathy caused by chemotherapy in patients with cancer.

Conditions:
  • Neurotoxicity
  • Pain
  • Peripheral Neuropathy
  • Unspecified Adult Solid Tumor, Protocol Specific


Total execution time in seconds: 0.22335290908813